{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:58:04Z","timestamp":1776135484010,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3403200"],"award-info":[{"award-number":["2023YFC3403200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20220818100402004"],"award-info":[{"award-number":["JCYJ20220818100402004"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Municipal Fundamental Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1111050001"],"award-info":[{"award-number":["2022B1111050001"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273841"],"award-info":[{"award-number":["82273841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbrc.2026.153594","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:03:06Z","timestamp":1773504186000},"page":"153594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and optimization of human glucocerebrosidase-encoding mRNA for Gaucher disease therapy"],"prefix":"10.1016","volume":"813","author":[{"given":"Shunping","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5982-8230","authenticated-orcid":false,"given":"Nino","family":"Rcheulishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-2636","authenticated-orcid":false,"given":"Dimitri","family":"Papukashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaiyang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaxia","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7409-7824","authenticated-orcid":false,"given":"Yang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3335-6794","authenticated-orcid":false,"given":"Peng George","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153594_bib1","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1056\/NEJM199111073251906","article-title":"Gaucher's disease","volume":"325","author":"Beutler","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153594_bib2","first-page":"730","article-title":"Selected items from the history of pathology: phillippe charles ernest gaucher (1854-1918)","volume":"95","author":"Prichard","year":"1979","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2026.153594_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbrc.2026.153594_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153594_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153594_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114402","article-title":"Lysosomal functions and dysfunctions: molecular and cellular mechanisms underlying gaucher disease and its association with parkinson disease","volume":"187","author":"Horowitz","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2026.153594_bib7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.153594_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175023","article-title":"Update of treatment for Gaucher disease","volume":"926","author":"Kong","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153594_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00109-021-02174-z","article-title":"Gaucher disease - more than just a rare lipid storage disease","volume":"100","author":"Roh","year":"2022","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbrc.2026.153594_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185913","article-title":"Real-world experiences with taliglucerase Alfa home infusions for patients with gaucher disease: a global cohort Study","volume":"12","author":"Revel-Vilk","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.153594_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1684","article-title":"Nanotechnology-based approaches for treating lysosomal storage disorders, a focus on fabry disease","volume":"13","author":"Abasolo","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bbrc.2026.153594_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114464","article-title":"Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders","volume":"188","author":"Del Grosso","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2026.153594_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.GIM.0000153660.88672.3C","article-title":"Individualization of long-term enzyme replacement therapy for Gaucher disease","volume":"7","author":"Andersson","year":"2005","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2026.153594_bib14","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/bjh.15402","article-title":"How we manage gaucher disease in the era of choices","volume":"182","author":"Revel-Vilk","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2026.153594_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MOP.0b013e32834c20d9","article-title":"Enzyme replacement therapy for lysosomal storage diseases","volume":"23","author":"Lachmann","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.bbrc.2026.153594_bib16","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.7150\/ijbs.87741","article-title":"A review on Gaucher disease: therapeutic potential of beta-glucocerebrosidase-targeted mRNA\/saRNA approach","volume":"20","author":"Feng","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.153594_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153594_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ajhg.2019.02.003","article-title":"Systemic mRNA therapy for the treatment of fabry disease: preclinical studies in wild-type mice, fabry Mouse model, and wild-type non-human Primates","volume":"104","author":"Zhu","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2026.153594_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12338","article-title":"CRISPaint allows modular base-specific gene tagging using a ligase-4-dependent mechanism","volume":"7","author":"Schmid-Burgk","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153594_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.bbrc.2026.153594_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.omtn.2022.10.003","article-title":"Cytidine-containing tails robustly enhance and prolong protein production of synthetic mRNA in cell and in vivo","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbrc.2026.153594_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf1412","article-title":"PolyA tail segmentation improves the stability of the template DNA and increases the translatability of in vitro transcribed mRNA","volume":"54","author":"Spiewla","year":"2026","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153594_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41434-025-00549-2","article-title":"Systemically delivered lipid nanoparticle-mRNA encoding lysosomal acid \u03b2-glucosidase restores the enzyme deficiency in a murine Gaucher disease model","volume":"32","author":"Liu","year":"2025","journal-title":"Gene Ther."},{"issue":"Volume 6","key":"10.1016\/j.bbrc.2026.153594_bib24","article-title":"Engineering synthetic and recombinant human lysosomal \u03b2-glucocerebrosidase for enzyme replacement therapy for Gaucher disease","volume":"6","author":"Souza Figueiredo","year":"2024","journal-title":"Discov. Appl. Sci."},{"key":"10.1016\/j.bbrc.2026.153594_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157089","article-title":"Development of a lentiviral vector for high-yield production of synthetic and recombinant GCase for gaucher disease therapy","volume":"26","author":"Coelho","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153594_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.htct.2023.09.1512","article-title":"A novel synthetic and RECOMBINANT glucocerebrosidase for gaucher disease: in silico molecular evolution and gene therapy approaches to enhance enzyme activity","volume":"45","author":"Figueiredo","year":"2023","journal-title":"Hematology, Transfusion and Cell Therapy"},{"key":"10.1016\/j.bbrc.2026.153594_bib27","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.ymthe.2025.05.003","article-title":"FLT201, a novel liver-directed AAV gene therapy candidate for gaucher disease type 1","volume":"33","author":"Comper","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2026.153594_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112884","article-title":"Self-amplifying RNA approach for protein replacement therapy","volume":"23","author":"Papukashvili","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.153594_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41541-023-00672-4","article-title":"Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa","volume":"8","author":"Wang","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.bbrc.2026.153594_bib30","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1016\/j.ymthe.2025.09.025","article-title":"Harnessing mRNA-encoded PcrV-targeting monoclonal antibodies for combating antibiotic-resistant P. aeruginosa infections","volume":"33","author":"Wang","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2026.153594_bib31","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1038\/s41467-025-62529-9","article-title":"Computational identification of small molecules for increased gene expression by synthetic circuits in mammalian cells","volume":"16","author":"Pisani","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153594_bib32","article-title":"Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery","author":"Gan Zhao","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2026.153594_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113641","article-title":"Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases","volume":"381","author":"Moosavi","year":"2025","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2026.153594_bib34","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/acsnano.3c09817","article-title":"Targeted mRNA nanoparticles ameliorate blood-brain barrier disruption postischemic stroke by modulating microglia polarization","volume":"18","author":"Gao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2026.153594_bib35","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/acschembio.5c00039","article-title":"Optimizing peptide-conjugated lipid nanoparticles for efficient siRNA delivery across the blood-brain barrier and treatment of glioblastoma multiforme","volume":"20","author":"Tong","year":"2025","journal-title":"ACS Chem. Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2600358X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X2600358X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:09:07Z","timestamp":1776132547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X2600358X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":35,"alternative-id":["S0006291X2600358X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153594","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and optimization of human glucocerebrosidase-encoding mRNA for Gaucher disease therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153594"}}